How Syria Became the Middle East’s Drug Dealer

November 4, 2024

Publication

The New Yorker

Read time

1 min

Nardello & Co. Managing Director Christopher Urben spoke with Ed Caesar of The New Yorker about the Syrian government’s involvement with the drug market in the Middle East. The region has seen an increase in demand for an amphetamine commonly referred to as Captagon, the spread of which is being enabled by the government of Syrian President Bashar al-Assad.

Chris explains, “The Assad regime was organizing this on a massive scale” and partnered with Hezbollah… “because they’re experts in terms of transportation, facilitation, and corruption in those regions and outside those regions – corruption at ports, money laundering.”

Read more

Tags

Why risk it?

Contact us